The untreated PRMT5 KO tumors exhibited a 46% reduction in tumor volume compared to the untreated WT tumors (958.5 mm3 vs. 1765.5 mm3, p = 0.009) (Figure 2C). Here, PRMT5 is linked to neoplasm.